IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 73 filers reported holding IGM BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $154,000 | +5033.3% | 22,340 | +7297.4% | 0.00% | – |
Q1 2024 | $3,000 | -93.8% | 302 | -94.7% | 0.00% | – |
Q4 2023 | $48,000 | -7.7% | 5,713 | -7.9% | 0.00% | – |
Q3 2023 | $52,000 | +4.0% | 6,203 | +13.9% | 0.00% | – |
Q2 2023 | $50,000 | -25.4% | 5,445 | +11.3% | 0.00% | – |
Q1 2023 | $67,000 | -26.4% | 4,892 | -9.3% | 0.00% | – |
Q4 2022 | $91,000 | -8.1% | 5,395 | +24.6% | 0.00% | – |
Q3 2022 | $99,000 | +167.6% | 4,329 | +110.5% | 0.00% | – |
Q2 2022 | $37,000 | -43.9% | 2,057 | -17.8% | 0.00% | – |
Q1 2022 | $66,000 | -38.3% | 2,503 | -31.4% | 0.00% | – |
Q4 2021 | $107,000 | -94.3% | 3,651 | -87.3% | 0.00% | – |
Q3 2021 | $1,890,000 | -20.6% | 28,744 | +0.4% | 0.00% | -100.0% |
Q2 2021 | $2,381,000 | +33.6% | 28,621 | +23.2% | 0.00% | 0.0% |
Q1 2021 | $1,782,000 | +901.1% | 23,229 | +1052.8% | 0.00% | – |
Q4 2020 | $178,000 | +19.5% | 2,015 | +0.1% | 0.00% | – |
Q3 2020 | $149,000 | +1.4% | 2,012 | 0.0% | 0.00% | – |
Q2 2020 | $147,000 | +10.5% | 2,012 | -15.4% | 0.00% | – |
Q1 2020 | $133,000 | +49.4% | 2,379 | +1.8% | 0.00% | – |
Q4 2019 | $89,000 | – | 2,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |